Companiesandmarkets.com

Research dominates the proteomics market with a 32% value share

Press Release   •   Jun 13, 2013 13:40 BST

Research values within the proteomics market has been forecast to increase at a compound annual growth rate (CAGR) of 9.7% over the next five years, increasing from a value of $1.8 billion at the end of 2012, to hit a total of $2.9 billion by 2017.

Proteomics is the large-scale study of proteins, particularly their structures and functions. Proteins are vital parts of living organisms, as they are the main components of the physiological metabolic pathways of cells.

There is an urgent need in the life science industry for technologies and products that can analyse and study the human proteome in a high-throughput, multiplex and low-cost way. Proteomic technologies are evolving to meet more of these needs, so it is important to keep abreast of these dynamics.

The proteomics industry is extremely diverse, with intense competition in many market segments. The industry contains a range of lifecycle technologies, which makes it attractive to companies that can innovate in early or emerging market segments.

Proteomics technologies have proven to be indispensable tools within the life-science industries, and they will continue to provide opportunities for innovators in the future.

Exciting developments likely to affect the future of proteomics include platforms with both genomic and proteomic content, the use of next-generation sequencing platforms for proteomics analysis, the development of novel protein and peptide affinity chemistries, and label-free methods.

The two key proteomic technologies - mass spectrometry and biochips - are benefiting from an explosion of new proteomics content from the large-scale genomic and proteomic initiatives. This proteomic content is driving the discovery of new biomarkers that are important in disease processes.

At the same time, improvements in technologies are driving proteomic applications. Increasing miniaturization and integration of biochip devices, as well as improvement in mass spectrometry workflow and instruments, are creating new applications in drug discovery and development and diagnostics.

For more information on the proteomics market, see the latest research: Proteomics Market

Follow us on Twitter @CandMResearch

Companiesandmarkets.com issues news updates and report summaries covering all major industries and sectors. The service provides additional client monitoring and timely alerts to breaking industry and sector news leading the day's business headlines. News articles, written by our staff, contain additional analyst insight, providing value added insight for our readers. News updates and real-time alerts on newly-released market reports are also available from our Facebook page, Twitter feed @CandMResearch and RSS links. We also welcome inquiries from business journalists and the news media.